Ultragenyx Pharmaceutical
RARE
$64.35
Share price
-3.58%
Change (1 day)
-18.25%
Change (1 year)
Categories
Revenue for Ultragenyx Pharmaceutical (RARE)
Revenue in 2024 (TTM): NZ$0.93 Billion
According to Ultragenyx Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is NZ$0.98 Billion. an increase over the revenue in the year 2023 that were of NZ$0.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ultragenyx Pharmaceutical from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | NZ$0.99 B | 44.66% |
| 2023 | NZ$0.68 B | 19.99% |
| 2022 | NZ$0.57 B | 11.23% |
| 2021 | NZ$0.51 B | 36.96% |
| 2020 | NZ$0.37 B | 143.92% |
| 2019 | NZ$0.15 B | 100.6% |
| 2018 | NZ$76.76 M | 1987.37% |
| 2017 | NZ$3.67 M | 1815.48% |
| 2016 | NZ$0.19 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | NZ$5.03 B | 409.42% | 🇺🇸 USA |
 | NZ$0.93 B | -5.70% | 🇺🇸 USA |
 | NZ$0.58 B | -40.68% | 🇺🇸 USA |
 | NZ$54.84 M | -94.45% | 🇺🇸 USA |